| abstract |
The present invention relates to a new use in therapy of a folinic substance or analogous to folinic acid, said use being characterized in that use is made of a substance chosen from the group comprising acid 5, 6,7,8-tetrahydrofolic, its derivatives and their mixtures, for obtaining an anti-platelet aggregation drug intended for a therapeutic indication in cases where it is advisable to inhibit or reduce the aggregation of blood platelets. |